Key result
Aortocaval shunt-induced volume overload spares global DNA methylation but alters 25 gene promoter regions.
Why the study?
Aberrant DNA methylation contributes to cardiac remodeling, but no study had examined cardiac DNA methylation upon exposure to volume overload.
Absolute Event Rate: 66.15% vs 64.92%
p-value: p=not significant
Volume overload induces specific, conserved DNA hypermethylation in the promoters of Jph2, Spcs3, Vapb, and Ipmk, which can be detected in peripheral blood and may serve as novel epigenetic biomarkers for LV dilatation and heart failure.
Promoter hypermethylation of Jph2, Spcs3, Vapb, and Ipmk in murine volume overload may mark early epigenetic changes; human validation studies are required before biomarker consideration.
Left ventricular (LV) dilatation, a prominent risk factor for heart failure (HF), precedes functional deterioration and is used to stratify patients at risk for arrhythmias and cardiac mortality. Aberrant DNA methylation contributes to maladaptive cardiac remodeling and HF progression following pressure overload and ischemic cardiac insults. However, no study has examined cardiac DNA methylation upon exposure to volume overload (VO) despite being relatively common among HF patients. We carried out global methylome analysis of LV harvested at a decompensated HF stage following exposure to VO induced by aortocaval shunt. VO resulted in pathological cardiac remodeling, characterized by massive LV dilatation and contractile dysfunction at 16 weeks after shunt. Although methylated DNA was not markedly altered globally, 25 differentially methylated promoter regions (DMRs) were identified in shunt vs. sham hearts (20 hypermethylated and 5 hypomethylated regions). The validated hypermethylated loci in Junctophilin-2 (Jph2), Signal peptidase complex subunit 3 (Spcs3), Vesicle-associated membrane protein-associated protein B (Vapb), and Inositol polyphosphate multikinase (Ipmk) were associated with the respective downregulated expression and were consistently observed in dilated LV early after shunt at 1 week after shunt, before functional deterioration starts to manifest. These hypermethylated loci were also detected peripherally in the blood of the shunt mice. Altogether, we have identified conserved DMRs that could be novel epigenetic biomarkers in dilated LV upon VO exposure.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2023) studied Volume overload-induced heart failure (n=44). Volume overload (aortocaval shunt) vs. Sham operation was evaluated on Global cytosine methylation patterns in CpG context (p=not significant). Volume overload induced by aortocaval shunt in female mice did not alter global DNA methylation but resulted in 25 differentially methylated promoter regions, including hypermethylated loci in Jph2, Spcs3, Vapb, and Ipmk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: